Primecap Management CO Amylyx Pharmaceuticals, Inc. Transaction History
Primecap Management CO
- $132 Billion
- Q1 2024
A detailed history of Primecap Management CO transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Primecap Management CO holds 10,000 shares of AMLX stock, worth $19,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 156,900
93.63%
Holding current value
$19,400
Previous $2.31 Million
98.79%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMLX
# of Institutions
181Shares Held
50.5MCall Options Held
5.82MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA5.35MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$8.68 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.94MShares$5.71 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.47MShares$4.79 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$4.02 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $114M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...